Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Serap Ortaç"'
Publikováno v:
Documenta Ophthalmologica. 105:301-312
Ocular complications of Behcet's disease can be severe and lead to blindness in 90% of untreated patients. We aimed to evaluate the long-term use of low dose cyclosporin-A (CsA) which is a potent immunomodulatory agent in the treatment of ocular Behc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e46cc2cdf2102171681fe8741fbb49fb
https://doi.org/10.1023/a:1021227019915
https://doi.org/10.1023/a:1021227019915
Publikováno v:
Annals Of Ophthalmology. 35:108-110
We evaluated the autonomic nervous system involvement in Behcet disease by pupillary responses. Pupil cycle times were 969±189 ms and 840±62 ms patient and control groups, respectively. This difference was statistically significant. Behcet disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1020f512bed281cc9a2144adf5e3777
https://doi.org/10.1385/ao:35:2:108
https://doi.org/10.1385/ao:35:2:108
Autor:
Melih Kurt, Sevim Kavuncu, Serap Ortaç, Feray Koç, Pinar Cakar Ozdal, Esin Firat, Buğra Eryüksel
Publikováno v:
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie. 243(11)
To assess the correlation between the serum leptin concentration and ocular involvement in patients with Behçet's disease.The study included 28 male consecutive patients with Behçet's disease ( group A, aged 19-59, median 35.5 years) and 15 male he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06f6b04aa735532a2e985663aedbe4ab
https://pubmed.ncbi.nlm.nih.gov/15906063
https://pubmed.ncbi.nlm.nih.gov/15906063
Publikováno v:
Japanese journal of ophthalmology. 47(1)
Purpose: Health-related quality of life (HRQOL) is an important outcome factor in chronic diseases such as Behcet syndrome. We aimed to investigate the relation of HRQOL to the duration of illness, mental state, and visual acuity of patients with Beh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f487c88ba6fb8ad13c2f9301893b6c03
https://pubmed.ncbi.nlm.nih.gov/12586184
https://pubmed.ncbi.nlm.nih.gov/12586184
Publikováno v:
Documenta ophthalmologica. Advances in ophthalmology. 105(3)
Ocular complications of Behçet's disease can be severe and lead to blindness in 90% of untreated patients. We aimed to evaluate the long-term use of low dose cyclosporin-A (CsA) which is a potent immunomodulatory agent in the treatment of ocular Beh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3e1c606d956c600db6b626b9fefbb210
https://pubmed.ncbi.nlm.nih.gov/12539855
https://pubmed.ncbi.nlm.nih.gov/12539855
Publikováno v:
Graefe's Archive of Clinical & Experimental Ophthalmology; Nov2005, Vol. 243 Issue 11, p1158-1160, 3p